Related documents Search history  |  Help

[ clip How a renowned scientist used her personal network to transform UTA’s North Texas Genome Center into a COVID-19 testing facility ]

3 document(s) related     Misc. items: 3

Articles / Press Releases
Clips
Sex differences in immune responses to SARS-CoV-2 that underlie disease outcomes (preprint). (Link Type: Article)
See: https://www.medrxiv.org/content/10.1101/2020.06.06.20123414v2
In medRxiv
By Takehiro Takahashi, et al.
Publication Date: June 26, 2020
   
Other
Clips
Letter to Quidel Corporation Senior Director, Clinical and Regulatory Affairs, Ronald Lollar regarding the use of Lyra Direct SARS-CoV-2 Assay by laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. § 263a, to perform high complexity tests (approval of Emergency Use Authorization). (Link Type: Letter)
See: https://www.fda.gov/media/138179/download
By RADM Denise M. Hinton, Chief Scientist, U.S. Food and Drug Administration (FDA)
Publication Date: May 18, 2020
   
Clinical Laboratory Improvement Amendments (CLIA) (includes links to related information). (Link Type: Website)
See: https://www.cdc.gov/clia/index.html
By Centers for Disease Control and Prevention (CDC) / U.S. Department of Health and Human Services
Publication Date: Accessed August 3, 2020